2013-2028 Report on Global Flu Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: Aug, 2019 | Pages: 102 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Synopsis

The global Flu Vaccine Market is expected to witness significant growth over the forecast period 2013 to 2028. The flu vaccines are biologic products. As soon as inoculated, these source the making of antibodies, which avert disease from the virus of influenza. The manufacture of antibodies in the person’s body begins during the period of two weeks of vaccination.

The vaccine for Influenza is too described as flu vaccine. It is utilized for shielding in contrast to the virus of influenza. This vaccine is a mixture of three influenza viruses that is to say, influenza type B virus strain, influenza type A with H1N1 virus strain and influenza type A with H3N2 virus strain. The vaccine for influenza is a twelve-monthly vaccine. It defends the person from receiving the type of respiratory sickness, flu sourced through a virus that spreads by means of the sneezes and coughs of an infected someone. It is able to advance to severe health problems and perhaps death of the patient.

Drivers

Additionally intended inhabitants and growing demand, in medium and low income nation states furthermore increasing alertness regarding flu vaccination sustained to pressure the development of the market for flu vaccine. A remarkable growth in healthcare expenditure all over the world together with increasing efforts to boost the speed of flu vaccination to control the eruption of communicable disease, has furthermore weigh up on similar level for the development of the market.

Restraints

On the other hand, the requirement for flu vaccine is mostly maintained by severity of seasonal flu through diverse geography. The irregular characteristics of the seasonal flu has directed to a gap of supply-demand. Furthermore, the production procedures of flu vaccine under strict sterilized condition hold months and consist of cleansing, testing for quality, controls for security & wrapping also controlling verifications which delay the access to vaccines for the duration of an eruption.

Classification

The global Flu Vaccine Market can be classified by Sales Network, Application, and Type.

By Sales Network, it can be classified as: Delivery Network, Direct Sales. By Application, it can be classified as: For Children age above 3 years& Adults. For Children age 6 months to 3years By Type, it can be classified as: Live Attenuated Virus Vaccines, Split Virus Vaccines, Subunit Vaccines, Quadrivalent Vaccine, Pandemic Vaccine and Whole Virus Vaccines.

Regional Lookout

By Region the global market for Flu Vaccine can be classified as North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. Between every part of the geographical regions, the U.S.A was the biggest flu vaccine industry during the historical years. It is intimately tracked by China. Similar to some other medicine, managing such a lethal communicable illness is challenges even now in front of healthcare division. The probability of incidence of seasonal flu is one and the same in emerging and developed nation states. Furthermore it is forecasted that the market for seasonal flu vaccine will considerably enlarge, because of greater percentage of infection across the people, during the period of upcoming years

The regions of America will be winning the share of the market for flu vaccine. This is mostly because of greater alertness. The Asia Pacific region will make up a greater incremental enlargement during the period of forecast as contrast to the regions of Europe, Middle East & Africa and America. The cause for the development of Asia Pacific is credited to the step up in consciousness regarding the vaccination of flu by together the companies operating in the industry and the government organizations.

Companies

Taking into consideration solid initiatives for R&D actions and product multiplicity of important key stakeholders, the numeral small companies are presenting a different duality in their methodology. Over and above, holding out partnership with associations for example PAHO, WHO and GAVI, to present flu vaccine at reasonable price in emergent nation states

Minor companies are focused on taking over together provincial and local markets. The companies operating in the market for flu vaccine for example Panacea Biotec Limited, CNBG shanghai institute, Sinovac Biotech Ltd and Hualan Biological Engineering Inc.are strongly expected to go after these policies for the duration of the forecast.

Some of the important companies for Flu Vaccine Market are: Johnson & Johnson, AstraZeneca, Sanofi Pasteur, CSL, Pfizer, Mylan, Glaxo Smith Kline plc. (GSK.), Serum Institute of India Pvt. Ltd.

Other distinguished companies are: Panacea Biotec Limited, CNBG shanghai institute, Sinovac Biotech Ltd, Hualan Biological Engineering Inc., Simcere Vaxtec, Aimei Hissen, SIOBP, Ad immune, Aleph Biomedical, Tianyuan Bio-Pharma(Novartis), Changsheng Biological, ZYAK and CCBIO.

The global Flu Vaccine market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Flu Vaccine from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Flu Vaccine market.

Leading players of Flu Vaccine including:

• CSL
• GSK
• Sanofi Pasteur
• Mylan
• AstraZeneca
• Pfizer
• Johnson & Johnson

Market split by Type, can be divided into:

• Whole Virus Vaccines
• Split Virus Vaccines
• Subunit Vaccines
• Live Attenuated Virus Vaccines

Market split by Application, can be divided into:

• For Children (6 months to 3 years)
• For Adults and Children over 3 years

Market split by Sales Channel, can be divided into:

• Direct Channel
• Distribution Channel

Market segment by Region/Country including:

• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Spain etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
• South America Brazil, Argentina, Colombia and Chile etc.)
• Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 Flu Vaccine Market Overview
    1.1 Flu Vaccine Definition
    1.2 Global Flu Vaccine Market Size Status and Outlook (2013-2028)
    1.3 Global Flu Vaccine Market Size Comparison by Region (2013-2028)
    1.4 Global Flu Vaccine Market Size Comparison by Type (2013-2028)
    1.5 Global Flu Vaccine Market Size Comparison by Application (2013-2028)
    1.6 Global Flu Vaccine Market Size Comparison by Sales Channel (2013-2028)
    1.7 Flu Vaccine Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Flu Vaccine Market Segment Analysis by Player
    2.1 Global Flu Vaccine Sales and Market Share by Player (2016-2018)
    2.2 Global Flu Vaccine Revenue and Market Share by Player (2016-2018)
    2.3 Global Flu Vaccine Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player

Chapter 3 Flu Vaccine Market Segment Analysis by Type
    3.1 Global Flu Vaccine Market by Type
        3.1.1 Whole Virus Vaccines
        3.1.2 Split Virus Vaccines
        3.1.3 Subunit Vaccines
        3.1.4 Live Attenuated Virus Vaccines
    3.2 Global Flu Vaccine Sales and Market Share by Type (2013-2018)
    3.3 Global Flu Vaccine Revenue and Market Share by Type (2013-2018)
    3.4 Global Flu Vaccine Average Price by Type (2013-2018)
    3.5 Leading Players of Flu Vaccine by Type in 2018
    3.6 Conclusion of Segment by Type

Chapter 4 Flu Vaccine Market Segment Analysis by Application
    4.1 Global Flu Vaccine Market by Application
        4.1.1 For Children (6 months to 3 years)
        4.1.2 For Adults and Children over 3 years
    4.2 Global Flu Vaccine Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Flu Vaccine by Application in 2018
    4.4 Conclusion of Segment by Application

Chapter 5 Flu Vaccine Market Segment Analysis by Sales Channel
    5.1 Global Flu Vaccine Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Flu Vaccine Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Flu Vaccine by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel

Chapter 6 Flu Vaccine Market Segment Analysis by Region
    6.1 Global Flu Vaccine Market Size and CAGR by Region (2013-2028)
    6.2 Global Flu Vaccine Sales and Market Share by Region (2013-2018)
    6.3 Global Flu Vaccine Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Flu Vaccine Market Share by Type
        6.4.3 North America Flu Vaccine Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Flu Vaccine Market Share by Type
        6.5.3 Europe Flu Vaccine Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Flu Vaccine Market Share by Type
        6.6.3 Asia-Pacific Flu Vaccine Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Flu Vaccine Market Share by Type
        6.7.3 South America Flu Vaccine Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Flu Vaccine Market Share by Type
        6.8.3 Middle East & Africa Flu Vaccine Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Flu Vaccine Players
    7.1 CSL
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 GSK
    7.3 Sanofi Pasteur
    7.4 Mylan
    7.5 AstraZeneca
    7.6 Pfizer
    7.7 Johnson & Johnson

Chapter 8 Upstream and Downstream Analysis of Flu Vaccine
    8.1 Industrial Chain of Flu Vaccine
    8.2 Upstream of Flu Vaccine
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Flu Vaccine
        8.3.1 Leading Distributors/Dealers of Flu Vaccine
        8.3.2 Leading Consumers of Flu Vaccine

Chapter 9 Development Trend of Flu Vaccine (2019-2028)
    9.1 Global Flu Vaccine Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Flu Vaccine Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Flu Vaccine Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Flu Vaccine Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Flu Vaccine Market Size Forecast by Sales Channel (2019-2028)

Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure Flu Vaccine Example
    Figure Global Flu Vaccine Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Flu Vaccine Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Flu Vaccine Sales Comparison by Type (2013-2028)
    Figure Global Flu Vaccine Sales Comparison by Application (2013-2028)
    Figure Global Flu Vaccine Sales Comparison by Sales Channel (2013-2028)
    Table Global Flu Vaccine Sales by Player (2016-2018)
    Table Global Flu Vaccine Sales Market Share by Player (2016-2018)
    Figure Global Flu Vaccine Sales Market Share by Player in 2018
    Table Global Flu Vaccine Revenue (Million $) by Player (2016-2018)
    Table Global Flu Vaccine Revenue Market Share by Player (2016-2018)
    Figure Global Flu Vaccine Revenue Market Share by Player in 2018
    Table Global Flu Vaccine Average Price by Player (2016-2018)
    Figure Global Flu Vaccine Average Price by Player in 2018
    Figure Global Flu Vaccine Players Competition Situation - Top 5 Players' Revenue Market Share in 2016
    Figure Global Flu Vaccine Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Whole Virus Vaccines
    Figure Global Whole Virus Vaccines Sales and Growth Rate (2013-2018)
    Figure Example of Split Virus Vaccines
    Figure Global Split Virus Vaccines Sales and Growth Rate (2013-2018)
    Figure Example of Subunit Vaccines
    Figure Global Subunit Vaccines Sales and Growth Rate (2013-2018)
    Figure Example of Live Attenuated Virus Vaccines
    Figure Global Live Attenuated Virus Vaccines Sales and Growth Rate (2013-2018)
    Table Global Flu Vaccine Sales by Type (2013-2018)
    Table Global Flu Vaccine Sales Market Share by Type (2013-2018)
    Figure Global Flu Vaccine Sales Market Share by Type in 2018
    Table Global Flu Vaccine Revenue (Million $) by Type (2013-2018)
    Table Global Flu Vaccine Revenue Market Share by Type (2013-2018)
    Figure Global Flu Vaccine Revenue Market Share by Type in 2018
    Table Global Flu Vaccine Average Price by Type (2013-2018)
    Figure Global Flu Vaccine Average Price by Type in 2018
    Table Leading Players of Flu Vaccine by Type in 2018
    Figure Example of For Children (6 months to 3 years)
    Figure Global Flu Vaccine for For Children (6 months to 3 years) Sales and Growth Rate (2013-2018)
    Figure Example of For Adults and Children over 3 years
    Figure Global Flu Vaccine for For Adults and Children over 3 years Sales and Growth Rate (2013-2018)
    Table Global Flu Vaccine Sales by Application (2013-2018)
    Table Global Flu Vaccine Sales Market Share by Application (2013-2018)
    Figure Global Flu Vaccine Sales Market Share by Application in 2018
    Table Leading Consumers of Flu Vaccine by Application in 2018
    Figure Example of Direct Channel
    Figure Global Flu Vaccine for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Flu Vaccine for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Flu Vaccine Sales by Sales Channel (2013-2018)
    Table Global Flu Vaccine Sales Market Share by Sales Channel (2013-2018)
    Figure Global Flu Vaccine Sales Market Share by Sales Channel in 2018
    Table Leading Distributors/Dealers of Flu Vaccine by Sales Channel in 2018
    Table Global Flu Vaccine Market Size and CAGR by Region (2013-2028)
    Table Global Flu Vaccine Sales by Region (2013-2018)
    Table Global Flu Vaccine Sales Market Share by Region (2013-2018)
    Figure Global Flu Vaccine Sales Market Share by Region in 2018
    Table Global Flu Vaccine Revenue (Million $) by Region (2013-2018)
    Table Global Flu Vaccine Revenue Market Share by Region (2013-2018)
    Figure Global Flu Vaccine Revenue Market Share by Region in 2018
    Table North America Flu Vaccine Sales by Country (2013-2018)
    Figure North America Flu Vaccine Sales Market Share by Country (2013-2018)
    Table North America Flu Vaccine Revenue by Country (2013-2018)
    Figure North America Flu Vaccine Revenue Market Share by Country (2013-2018)
    Figure North America Flu Vaccine Sales Market Share by Type in 2018
    Figure North America Flu Vaccine Sales Market Share by Application in 2018
    Figure United States Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure United States Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Canada Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Mexico Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Flu Vaccine Sales by Country (2013-2018)
    Figure Europe Flu Vaccine Sales Market Share by Country (2013-2018)
    Table Europe Flu Vaccine Revenue by Country (2013-2018)
    Figure Europe Flu Vaccine Revenue Market Share by Country (2013-2018)
    Figure Europe Flu Vaccine Sales Market Share by Type in 2018
    Figure Europe Flu Vaccine Sales Market Share by Application in 2018
    Figure Germany Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Germany Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure UK Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure France Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Italy Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Russia Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Spain Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Flu Vaccine Sales by Country (2013-2018)
    Figure Asia-Pacific Flu Vaccine Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Flu Vaccine Revenue by Country (2013-2018)
    Figure Asia-Pacific Flu Vaccine Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Flu Vaccine Sales Market Share by Type in 2018
    Figure Asia-Pacific Flu Vaccine Sales Market Share by Application in 2018
    Figure China Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure China Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Japan Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Korea Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure India Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Australia Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Flu Vaccine Sales by Country (2013-2018)
    Figure South America Flu Vaccine Sales Market Share by Country (2013-2018)
    Table South America Flu Vaccine Revenue by Country (2013-2018)
    Figure South America Flu Vaccine Revenue Market Share by Country (2013-2018)
    Figure South America Flu Vaccine Sales Market Share by Type in 2018
    Figure South America Flu Vaccine Sales Market Share by Application in 2018
    Figure Brazil Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Brazil Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Argentina Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Colombia Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Chile Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Flu Vaccine Sales by Country (2013-2018)
    Figure Middle East & Africa Flu Vaccine Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Flu Vaccine Revenue by Country (2013-2018)
    Figure Middle East & Africa Flu Vaccine Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Flu Vaccine Sales Market Share by Type in 2018
    Figure Middle East & Africa Flu Vaccine Sales Market Share by Application in 2018
    Figure Egypt Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Egypt Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure South Africa Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Flu Vaccine Sales and Growth Rate (2013-2018)
    Figure Nigeria Flu Vaccine Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of CSL
    Table Flu Vaccine Introduction of CSL
    Table Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share of CSL (2016-2018)
    Table Industrial Chain of Flu Vaccine
    Table Manufacturing Cost Structure of Flu Vaccine
    Table General Manufacturing Process of Flu Vaccine
    Table Leading Distributors/Dealers of Flu Vaccine
    Table Leading Consumers of Flu Vaccine
    Figure Global Flu Vaccine Sales and Growth Rate Forecast (2019-2028)
    Figure Global Flu Vaccine Revenue and Growth Rate Forecast (2019-2028)
    Table Global Flu Vaccine Market Size and CAGR Forecast by Region (2019-2028)
    Table Global Flu Vaccine Market Size and CAGR Forecast by Type (2019-2028)
    Table Global Flu Vaccine Market Size and CAGR Forecast by Application (2019-2028)
    Table Global Flu Vaccine Market Size and CAGR Forecast by Sales Channel (2019-2028)